Latest News

November 01, 2011
An experimental drug called Ocrelizumab has shown promise in a Phase 2 clinical trial involving 220 people with multiple sclerosis (MS), an often debilitating, chronic autoimmune disease that affects an increasing number of people in North America.
November 01, 2011
The UCSF “D’Vice Squad,” a group of innovators from across the Bay Area, has drawn from diverse disciplines over the last two years to develop medical devices for children.  
October 31, 2011
Scientists at the Gladstone Institutes have discovered how a form of the protein linked to Huntington’s disease influences the timing and severity of its symptoms, offering new avenues for treating not only this disease, but also a variety of similar conditions.
October 28, 2011
The San Francisco Bay Area Science Festival offers more than 100 mostly free events to put science and technology at everybody's fingertips and to encourage the next generation of scientists and innovators.
October 28, 2011
UCSF's leading scientists will participate in five discussions about fascinating topics, such as managing stress to retraining the brain for better performance, as part of the first-ever Bay Area Science Festival.
October 27, 2011
A large, international clinical trial led by doctors at UCSF indicates that a vaccine to prevent anal cancer is safe and effective, according to a study reported in the October 27, 2011 issue of New England Journal of Medicine.
October 27, 2011
UCSF will celebrate “Clinical Research Education Day’’ as the host of Aware for All – San Francisco, a free health education program that is open to the public and designed to help people make informed decisions about participating in clinical research.
October 26, 2011
The California Institute for Quantitative Biosciences (QB3) has signed an agreement with the Johnson & Johnson Corporate Office of Science and Technology (COSAT) to fund University of California proof-of-concept research that brings innovative science to market.
October 26, 2011
An 11-month-old partnership between UCSF and Pfizer, Inc., aimed at rapidly moving new therapies into human clinical trials, has selected its first projects for funding and joint development.
October 26, 2011
Three UCSF volunteers are leading a $25-million fundraising campaign to raise funds for brain cancer treatment and research.

Pages